Pharmacodynamics and tolerance of oral sustained release ritodrine

Frank R. Witter, Thomas J. Benedetti, Brent G. Petty, Arthur M. Feldman, Thomas A. Traiil, Judy Anderson

Research output: Contribution to journalArticlepeer-review

Abstract

A new oral sustained release formulation of ritodrine was tested for patient tolerance in this open study. The doses tested were 120 mg/day, 240 mg/day, and 360 mg/day. No objective toxicity was seen at any level. Doses of 120 mg/day and 240 mg/day were well-tolerated. Of the subjects who received the 360 mg/day dose, most tolerated it well.

Original languageEnglish (US)
Pages (from-to)690-695
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume159
Issue number3
DOIs
StatePublished - Jan 1 1988

Keywords

  • Ritodrine
  • drug levels
  • oral sustained release
  • pharmacodynamics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Pharmacodynamics and tolerance of oral sustained release ritodrine'. Together they form a unique fingerprint.

Cite this